Director
Barbara has more than 15 years of experience as a biostatistician, including five years as a statistical reviewer at FDA.
Barbara comes to Myraqa from a ten-year career as an independent consultant where she specialized in the design and analysis of molecular diagnostic studies and drug clinical trials. In addition to consulting on study design for molecular diagnostics and drug clinical trials, Barbara provided analysis for validation studies and genome-wide studies on SNPs and CNVs.
Barbara earned an MS in Biostatistics from Harvard University. She also holds a BA in Economics from Vassar College.
